Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
archive
fda
medical
boston
boston blog main
boston top stories
life sciences
national blog main
national top stories
postpartum depression
sage therapeutics
allopregnanolone
biotech
brexanalone
brexanolone
clinical data
clinical trials
depression
drugs
government
healthcare
jeff jonas
major depressive disorder
marc goodman
marinus pharmaceuticals
medicine
mental illness
mike cloonan
neuroscience
new york blog main
new york top stories
phase 3 trial
psychiatric disorders
research
steven kanes
svb leerink
zulresso
What
depression
5
×
fda
5
×
drug
approved
disorder
medication
treat
treatment
administration
anti
antidepressant
anxiety
approval
bit
breakthrough
brexanalone
brexanolone
called
caused
company
compound
coronavirus
demand
depressant
designation
devastating
esketamine
fast
food
gets
granted
hits
hour
infusion
investigation
major
mark
mdd
med
medical
Language
unset
Current search:
fda
×
depression
×
@slashgear.com
4 years ago
Popular antidepressant in short supply because of pandemic, says FDA
@slashgear.com
4 years ago
Another company gets FDA designation to treat depression with psilocybin
@slashgear.com
5 years ago
This nasal spray stops med-resistant depression in trials
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges